MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional World ex U.S. Core Equity 2 ETF (NY:DFAX)

31.47 -0.23 (-0.73%)
Streaming Delayed Price Updated: 12:52 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dimensional World ex U.S. Core Equity 2 ETF

< Previous 1 2 Next >
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report
Via Stocktwits
Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe
In addition to the submission to the EMA, Novo Nordisk aims to make the higher dose of Wegovy widely available throughout the European Union. 
Via Stocktwits
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants
The company said that it now expects rapid approval for the treatment in eight African countries, including Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, Uganda, and Tanzania. 
Via Stocktwits
Topics Death Government
Stellantis Production In Italy Slumps 27% In H1 2025: Union Now Expects Slump In Annual Numbers
The union expects the carmaker to produce 440,000 vehicles across its six assembly plants in Italy this year, including 250,000 passenger cars. 
Via Stocktwits
US Regulator Initiates Recall Query Into Nearly 1.2M Stellantis Ram Trucks: Retail Sentiment Dips
NHTSA said that it received 14 vehicle owner questionnaire reports and six death and injury reports under its Early Warning Reporting program describing failures of the Brake Transmission Shift... 
Via Stocktwits
Topics Product Recall
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish
Giant cell arteritis (GCA) is the most common form of systemic vasculitis, a group of rare autoimmune diseases characterized by inflammation of blood vessels. 
Via Stocktwits
Stellantis’ US Sales Drop Results In Downgrade At Wolfe, Firm Flags ‘Meaningful Risk’ To 2025, 2026 Earnings
Wolfe models about a €1 billion loss in North America this year, versus the consensus call for a roughly €1.6 billion profit, and added that "even this may be optimistic." 
Via Stocktwits
Toyota’s US Sales Rise 7.2% In Q2 Despite A Dull June: Here’s What Drove Demand For The Japanese Carmaker
In the three months through the end of June, Toyota Motor reported sales of 666,469 vehicles in the U.S. 
Via Stocktwits
Li Auto Stock Drops Pre-Market After EV Maker Lowers Q2 Delivery Outlook: Retail Remains Bullish
Li Auto had previously said that it expects to deliver between 123,000 and 128,000 vehicles in Q2. 
Via Stocktwits
Restaurant Brands Seizes Full Control Of Burger King China In $158M Deal: Retail Stays Bullish
The company said its long-term strategy has been to partner with “experienced local operators” while maintaining a primarily franchised business 
Via Stocktwits
Restaurant Brands International Stock In Focus After Q4 Earnings Beat, Burger King Revamp Plan: Retail Cheers
For 2025, Restaurant Brands said it plans up to $2.48 in dividends per common share and partnership exchangeable unit of RBI LP 
Via Stocktwits
Topics Earnings
Smirnoff Parent Diageo’s Stock In Spotlight After Company Warns of $200M Impact From Trump Tariffs: Retail’s Extremely Bearish
The impact would impact mainly its tequila products, which must be made in Mexico 
Via Stocktwits
Topics Government
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story